RAYMOND JAMES & ASSOCIATES - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 118 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.85 and the average weighting 0.5%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$201,000
+16.2%
40,198
+64.3%
0.00%
Q1 2021$173,000
-78.1%
24,460
-80.6%
0.00%
-100.0%
Q4 2020$790,000
-0.8%
126,208
-21.0%
0.00%0.0%
Q3 2020$796,000
+325.7%
159,762
+345.0%
0.00%
Q2 2020$187,000
+61.2%
35,898
-2.8%
0.00%
Q1 2020$116,000
-38.0%
36,948
-20.3%
0.00%
Q4 2019$187,000
-25.8%
46,348
-20.5%
0.00%
Q3 2019$252,000
-25.0%
58,323
-30.7%
0.00%
Q2 2019$336,000
-30.3%
84,123
-6.4%
0.00%
-100.0%
Q1 2019$482,000
-4.6%
89,865
-8.8%
0.00%0.0%
Q4 2018$505,000
-47.2%
98,528
-0.1%
0.00%0.0%
Q3 2018$957,000
+6.0%
98,675
+11.4%
0.00%
-50.0%
Q2 2018$903,000
-21.5%
88,573
+0.1%
0.00%0.0%
Q1 2018$1,150,000
+166.2%
88,494
+266.3%
0.00%
+100.0%
Q4 2017$432,000
+49.5%
24,157
+109.6%
0.00%0.0%
Q3 2017$289,00011,5250.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders